Abstract | OBJECTIVE: gamma-Hydroxybutyrat (GHB) is used medically for narcolepsy and as a narcotic. It is also a rare illegal drug. In this case report the development of a GHB-dependency against the background of a primary alcohol dependency is described. METHODS: Based on established alcohol withdrawal scales (AWSS by Wetterling, CIWA) and neuropsychological testing procedures (CGI, GAF, SKID-II, PISQ, analog-scale for Craving), the initial situation, the development of psychopathological findings, and the course of detoxification were shown. RESULTS/CONCLUSION: The combined detoxication of GHB and alcohol was successfully finished by a reduction schedule of diazepam. Withdrawal-assessment scales for alcohol were helpful, but show limitations for GHB- withdrawal symptoms. The patient suffers, according to ICD-10, from a multiple drug dependence (alcohol, GHB, abstinence from amphetamines). Symptoms of insomnia, major depression, and generalized anxiety disorder can be associated with the use of GHB.
|
Authors | Christoph Richter, Alexander Romanowski, Thorsten Kienast |
Journal | Psychiatrische Praxis
(Psychiatr Prax)
Vol. 36
Issue 7
Pg. 345-7
(Oct 2009)
ISSN: 1439-0876 [Electronic] Germany |
Vernacular Title | Gamma-Hydroxybutyrat (GHB)-Abhängigkeit und -Entzug bei vorbestehender Alkoholabhängigkeit. |
PMID | 19173170
(Publication Type: Case Reports, Journal Article)
|
Copyright | Georg Thieme Verlag KG Stuttgart. New York. |
Chemical References |
- Adjuvants, Anesthesia
- Illicit Drugs
- Sodium Oxybate
|
Topics |
- Adjuvants, Anesthesia
(adverse effects)
- Adult
- Alcoholism
(psychology, rehabilitation)
- Comorbidity
- Drug Tolerance
- Humans
- Illicit Drugs
- Male
- Neuropsychological Tests
- Sodium Oxybate
- Substance Withdrawal Syndrome
(diagnosis, rehabilitation)
- Substance-Related Disorders
(psychology, rehabilitation)
- Treatment Outcome
|